Moreover, TGF-β signaling activation at late stages paradoxically promotes cancer cell metastasis by activating the epithelial-to-mesenchymal transition, modulating microenvironments and suppressing anti-tumor immune responses [61]. The gene discussed is TGFB1; the disease is cancer.